Accumulation of β- and γ-synucleins in the ubiquitin carboxyl-terminal hydrolase L1-deficient gad mouse
暂无分享,去创建一个
Rieko Setsuie | Hitoshi Osaka | Jungkee Kwon | K. Wada | J. Kwon | Y. Yoshikawa | H. Osaka | M. Noda | Rieko Setsuie | Mikako Sakurai | Keiji Wada | Yu-Lai Wang | Mami Noda | Yae Sato | Ying-Jie Sun | Mikako Sakurai | Yoko Hara | A. Furuta | Akiko Furuta | A. Takeda | Ayako Takeda | Yasuhiro Yoshikawa | Y. Hara | Yu-Lai Wang | Yae Sato | Ying-Jie Sun | Jungkee Kwon
[1] Edward J. Dick,et al. Expression of stress proteins alpha B-crystallin, ubiquitin, and hsp27 in pallido-nigral spheroids of aged rhesus monkeys , 2001, Neurobiology of Aging.
[2] H Shibasaki,et al. Progressive degeneration of motor nerve terminals in GAD mutant mouse with hereditary sensory axonopathy , 1993, Neuropathology and applied neurobiology.
[3] D. Price,et al. Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[4] R. Sidman,et al. Atlas of the Mouse Brain and Spinal Cord , 1971 .
[5] P. Mcgeer,et al. Two Types of Spheroid Bodies in the Nigral Neurons in Parkinson's Disease , 1991, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[6] J Q Trojanowski,et al. Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[7] John Q. Trojanowski,et al. Ubiquitination of α-Synuclein Is Not Required for Formation of Pathological Inclusions in α-Synucleinopathies , 2003 .
[8] J. Trojanowski,et al. Neurodegeneration with Brain Iron Accumulation, Type 1 Is Characterized by α-, β-, and γ-Synuclein Neuropathology , 2000 .
[9] T. Tomita,et al. Neuropathology of gracile axonal dystrophy (GAD) mouse , 1989, Acta Neuropathologica.
[10] Kaori Nishikawa,et al. Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron. , 2003, Human molecular genetics.
[11] Jimi Adu,et al. Persyn, a member of the synuclein family, influences neurofilament network integrity , 1998, Nature Neuroscience.
[12] J. Vickers,et al. Localization of α-, β-, and γ-synuclein during neuronal development and alterations associated with the neuronal response to axonal trauma , 2003, Experimental Neurology.
[13] A. Bizzi,et al. Axonal transport of two major components of the ubiquitin system: free ubiquitin and ubiquitin carboxyl-terminal hydrolase PGP 9.5 , 1991, Brain Research.
[14] Takayuki Harada,et al. Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice , 1999, Nature Genetics.
[15] K. Suzuki,et al. Pathological study of mice with total deficiency of sphingolipid activator proteins (SAP knockout mice) , 1998, Acta Neuropathologica.
[16] Matthew J. Farrer,et al. Comparison of kindreds with parkinsonism and α‐synuclein genomic multiplications , 2004 .
[17] Olaf Riess,et al. AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.
[18] Substance P-like immunoreactivity in the gracile nucleus and fasciculus in old mice , 1989, Neuroscience Letters.
[19] T. Iwanaga,et al. Expression of protein gene product 9.5, a neuronal ubiquitin C‐terminal hydrolase, and its developing change in Sertoli cells of mouse testis , 1999, Molecular reproduction and development.
[20] W. Honer,et al. Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders. , 1998, The American journal of pathology.
[21] Makoto Hashimoto,et al. β-Synuclein Inhibits α-Synuclein Aggregation A Possible Role as an Anti-Parkinsonian Factor , 2001, Neuron.
[22] C. Larsen,et al. Comparisons of neuronal (PGP 9.5) and non-neuronal ubiquitin C-terminal hydrolases. , 1992, Biochemical Society transactions.
[23] T. Hirokawa,et al. Alterations of structure and hydrolase activity of parkinsonism-associated human ubiquitin carboxyl-terminal hydrolase L1 variants. , 2003, Biochemical and biophysical research communications.
[24] T. Kikuchi,et al. Axonal degeneration of ascending sensory neurons in gracile axonal dystrophy mutant mouse , 2004, Acta Neuropathologica.
[25] J Q Trojanowski,et al. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α‐synuclein , 1998, Annals of neurology.
[26] Robert L. Nussbaum,et al. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .
[27] Y. Imai,et al. Parkin Suppresses Unfolded Protein Stress-induced Cell Death through Its E3 Ubiquitin-protein Ligase Activity* , 2000, The Journal of Biological Chemistry.
[28] Janel O. Johnson,et al. α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.
[29] T. Tomita,et al. Gracile Axonal Dystrophy (GAD), a New Neurological Mutant in the Mouse , 1988, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[30] J. Lowe,et al. Ubiquitin carboxyl‐terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases , 1990, The Journal of pathology.
[31] T. Yokoyama,et al. Neuropathology of chronic vitamine E deficiency in fatal familial intrahepatic cholestasis , 2004, Acta Neuropathologica.
[32] A. Davies,et al. Persyn, a Member of the Synuclein Family, Has a Distinct Pattern of Expression in the Developing Nervous System , 1998, The Journal of Neuroscience.
[33] T. Kikuchi,et al. AXONAL DEGENERATION IN THE CENTRAL NERVOUS SYSTEM OF GRACILE AXONAL DYSTROPHY (GAD) MICE PROGRESSES LIKE IN HUMAN SPINOCEREBELLAR ATAXIAS , 1991 .
[34] A. Gregory,et al. Neurodegeneration with brain iron accumulation. , 2005, Folia neuropathologica.
[35] N. Ichihara,et al. Axonal degeneration promotes abnormal accumulation of amyloid β-protein in ascending gracile tract of gracile axonal dystrophy (GAD) mouse , 1995, Brain Research.
[36] P. Lansbury,et al. The UCH-L1 Gene Encodes Two Opposing Enzymatic Activities that Affect α-Synuclein Degradation and Parkinson's Disease Susceptibility , 2002, Cell.
[37] E. Masliah,et al. C-terminal α-synuclein immunoreactivity in structures other than Lewy bodies in neurodegenerative disorders , 2000, Acta Neuropathologica.
[38] H. Braak,et al. Pallido-nigral spheroids in nonhuman primates: accumulation of heat shock proteins in astroglial processes , 2002, Acta Neuropathologica.
[39] M. Goedert,et al. Lewy body diseases and multiple system atrophy as α-synucleinopathies , 1998, Molecular Psychiatry.
[40] W. Halliday. The nosology of Hallervorden-Spatz disease , 1995, Journal of the Neurological Sciences.
[41] N. Arai. Grumose or foamy spheroid bodies involving astrocytes in the human brain , 1995, Neuropathology and applied neurobiology.
[42] A. Dehejia,et al. Identification, localization and characterization of the human γ-synuclein gene , 1998, Human Genetics.
[43] J. Aicardi,et al. Infantile neuroaxonal dystrophy. , 1979, Brain : a journal of neurology.